Synthetic 8-ornithine-vasopressin, a clinically used vasoconstrictor, causes cardiac effects mainly via changes in coronary flow

Acta Anaesthesiologica Scandinavica

Volumn 41, Issue 3, 1997, Pages 414-421

  Graf, B M ^a   Fischer, B ^b   Stowe, D F ^b   Bosnjak, Z J ^b   Martin, E O ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

8 Ornithine vasopressin; Coronary flow; Coronary perfusion pressure; Electrophysiology; Gregg's phenomenon; Isolated; Left; Oxygen consumption; Synthetic vasopressin agonist; Ventricular pressure

Indexed keywords

ORNIPRESSIN; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; DRUG INDICATION; ELECTROPHYSIOLOGY; GUINEA PIG; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; VASOCONSTRICTION;

EID: 0030932413     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1997.tb04708.x     Document Type: Article

References (38)

1. Klingenström P, Nylèn B, Westermark C. Vasoconstrictors and experimental flaps. Acta Chir Scand 1966: 131: 187-192.
2. Klingenström P, Nylèn B, Westermark L. A clinical comparison between adrenaline and octapressin as vasoconstrictors in local anaesthesia. Acta Anaesthesiol Scand 1967: 11: 35-42.
3. Miller SH, Buch OC, Woodward WR, Demuth RJ. Alterations in local blood flow and tissue gas tension caused by epinephrine. Plast Reconstr Surg 1984: 73: 797-803.
4. Klingenström K, Westermark L. Local tissue-oxygen tension after adrenaline, noradrenaline and octapressin in local anaesthesia. Acta Anaesthesial Scand 1964: 8: 261-266.
5. Björlin G. The influence of local anaesthetics on living tissues in white rat. Odont Rev 1954: suppl 2.
6. Katz R. Epinephrine and PLV-2: Cardiac rhythms and local vasoconstrictor effects. Anesthesiology 1965: 26: 619-626.
7. Corliss J, McKenna D, Sialer S, O'Brien GS, Rowe GG. Systemic and coronary hemodynamic effects of vasopressin. Am J Med Sci 1968: 256: 293-299.
8. Kramar J, McCarthy H, Grinnell E, Dietz N. The role of vasopressin in cardiac arrest. Am J Surg 1962: 103: 664-673.
9. Slotnik JL, Teigland JD. Cardiac accidents following vasopressin injection (Pitressin®). JAMA 1951: 146: 1126-1129.
10. Cartheuser C, Komarek J. Effects of vasopressin on the circulation, myocardial dynamics, and left ventricular oxygen consumption in the anaesthetized dog. Basic Res Cardiol 1980: 75: 668-682.
11. Einstein R, Angus JA, Cobbin LB, Goodman AH. Cardio-vascular effects of ornithine-8-vasopressin ("POR-8"). Med J Aust 1971: 2: 798-800.
12. Rintala A, Tammisto T. On surgical hemorrhages in relation to local anesthesia. I. Comparative clinical studies on the vasoconstricting action of epinephrine, norepinephrine and octapressin. [German]. Anaesthesist 1965: 14: 181-183.
13. Clodius L, Smahel J. FOR 8, a new vasoconstrictor substitute for adrenaline in plastic surgery. Br J Plast Surg 1970: 23: 73-76.
14. Coleman AJ, Baker LW. Some cardiovascular effects of ornithine-8-vasopressin: a new surgical vasoconstrictor agent. Br J Anaesth 1973: 45: 511-514.
15. Saarnivaara L, Leander P. Comparison of the haemostatic and cardiovascular effects of adrenaline and ornithine-8-vasopressin (POR 8) in middle ear operations. Anaesthesist 1977: 26:144-147.
16. Graf BM, Bohrer H. A fatal hypertensive reaction during anesthesia in a patient with acute subarachnoid hemorrhage. [German]. Anaesthesist 1990: 39: 434-438.
17. Abel M, Goebel A, von Gravert H. Supraventricular tachycardia following POR 8 (ornipressin)-administration in an infant. [German]. Anaesthesist 1987: 36: 653-654.
18. Veit S, Muser HG, Bottcher E, Bruckner JB. Signs of a severe myocardial ischemia following peritonsillar infiltration with ornipressin (POR 8). [German]. Anaesthesist 1993: 42: 320-323.
19. Poetcko C, Veit S, Brueckner J. Unerwünschte kardiovaskuläre und systemische Wirkungen von Ornipressin (POR-8®) und deren Therapie mit Dipyridamol (Persantin®). Eine tierexperimentelle Studie. Anaesthesist 1992: 37(Suppl): 150.
20. Veit S, Poethko C, Heidelmeyer CF, Bruckner JB. Ornipressin (POR 8) - effect on coronary blood circulation and the peripheral circulation. An animal experimental study. [German]. Anaesthesist 1993: 42: 597-604.
21. Stowe DF, Marjic J, Bosnjak ZJ, Kampine JP. Direct comparative effects of halothane, enflurane, isoflurane on oxygen supply and demand in isolated hearts. Anesthesiology 1991: 74: 1087-1095.
22. Hirlinger WK, Dell U, Pirsig W, Sigg O. POR 8 (ornipressin). Local vasoconstrictive effect and hemodynamic activity during surgery in ENT clinics. [German]. Anaesthesist 1984: 33: 149-153.
23. Altura BM, Altura BT. Actions of vasopressin, oxytocin, and synthetic analogs on vascular smooth muscle. Federation Proceedings 1984: 43: 80-86.
24. Boyle WA, Segel LD. Direct cardiac effects of vasopressin and their reversal by a vascular antagonist. Am J Physiol 1986: 251: H734-741.
25. Nakano J. Studies on the cardiovascular effects of synthetic vasopressin. J Pharmacol Exp Ther 1967: 157: 19-31.
26. Nakano J. Cardiovascular actions of vasopressin. [Review]. Jap Circ J (English Edition) 1973: 37: 363-381.
27. Wilson M, Brackett D, Archer L, Hinshaw L. Mechanism of impaired cardiac function by vasopressin. Ann Surg 1980: 191: 494-500.
28. Walker BR, Childs ME, Adams EM. Direct cardiac effects of vasopressin: role of V1- and V2-vasopressinergic receptors. Am J Physiol 1988: 255: H261-265.
29. 2+ channel current in guinea pig ventricular myocytes. Circ Res 1995: 76:592-599.
30. Gregg DE. Regulation of the collateral and coronary circulation of the heart. In: McMichael J, ed.: Circulation. Proceedings of the Harvey Tercentenary Congress. Oxford: Blackwell, 1958: 163-186
31. Arnold G, Kosche F, Miessner E, Neitzert A, Lochner W. The importance of the perfusion pressure in the coronary arteries for the contractility and the oxygen consumption of the heart. Eur J Physiol (Pflugers Arch) 1968: 299: 339-356.
32. Boatwright R, Downey H, Bashour F, Crystal G. Transmural variation in autoregulation of coronary blood flow in hyperperfused canine myocardium. Circ Res 1980: 47: 599-609.
33. Bai XJ, Iwamoto T, Williams AG, Fan WL, Downey HF. Coronary pressure-flow autoregulation protects myocardium from pressure-induced changes in oxygen consumption. Am J Physiol 1994: 266: H2359-H2368.
34. Graf BM, Stowe DF, Fischer B, Bosnjak ZJ, Martin E. Vaso3 pressin and myocardial oxygen demand - a model 1 for the Gregg's phenomenon. Anesthesiology 1995: 83 (suppl): A612.
35. Iwamoto T, Bai X, Williams Jr A, Downey H. Pressure related changes in regional myocardial contractility and internal resistance: mechanism of Gregg phenomenon (Abstract). J Mol Cell Cardiol 1993: 25: S87.
36. Brooks DP, Share L, Crofton JT, Nasjletti A. Interrelationship between central bradykinin and vasopressin in conscious rats. Brain Res 1986: 371: 42-48.
37. Maxwell GM. The cardiovascular effects of octapressin. Arch Int Pharmacodyn Ther 1965: 158: 17-23.
38. Rurak DW. Plasma vasopressin levels during hypoxaemia and the cardiovascular effects of exogenous vasopressin in foetal and adult sheep. J Physiol (Lond) 1978: 277: 341-357.